Allakos

$105.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.71 (+1.64%) As of 6:16 PM UTC today

Why Robinhood?

You can buy or sell Allakos and other stocks, options, and ETFs commission-free!

About ALLK

Allakos Inc. Common Stock, also called Allakos, is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis.

CEO
Robert Alexander
Employees
125
Headquarters
Redwood City, California
Founded
2012
Market Cap
5.82B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
163.05K
High Today
$106.00
Low Today
$103.19
Open Price
$103.62
Volume
47.70K
52 Week High
$157.98
52 Week Low
$55.51

ALLK Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

CIHKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure